I remember the moment clearly. A hot July day, standing at my mailbox, opening an envelope from a genetic testing company. I expected reassurance. Instead, I saw a result sitting in the bright red end of the risk continuum. As far from “OK” as it could get.
Years earlier, my son had mentioned that his 23andMe test showed he carried a gene that might lead to Alzheimer’s “when he was old.” …
Why the case against APOE4 testing no longer holds
Get free updates delivered free to your inbox.
